Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Concert Pharmaceuticals announces plans for CTP-543 phase 3 trials in alopecia areata

pharmaceutical-business-reviewApril 06, 2020

Tag: Concert Pharmaceuticals , CTP-543 , Alopecia areata

PharmaSources Customer Service